Cite
HARVARD Citation
Hendifar, A. et al. (2014). Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer. Expert review of anticancer therapy. 14 (9), pp. 1051-1061. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hendifar, A. et al. (2014). Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer. Expert review of anticancer therapy. 14 (9), pp. 1051-1061. [Online].